Only one article has demonstrated that CFTR modulators can reduce excessive pro-inflammatory response following LPS (lipopolysaccharide) stimulation of CF monocytes (Jarosz-Griffiths et al., 2020). This evidence concerns the gene CFTR and cystic fibrosis.